Saeed Dabestani
@DrDabestani
Followers
377
Following
867
Statuses
666
Consultant Urologist, M.D. Ph.D. Associate Professor. @Uroweb EAU RCC GL Panel member. RFL Renal Cancer 🤖 Fellow Alumni. 👨👧👧,🤹🏽, 👨🔬 Views my own.
Joined April 2014
RT @Ric_Campi: 💡Updated @Uroweb Guidelines on the Use of #Adjuvant Immune Checkpoint Inhibitors and #Subsequent Therapy for Renal Cell Car…
0
21
0
0
0
2
Very interesting read! Title says it all. Great job by @TJammihal, @Sachetshukla and @DanaFarber Team. "Immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma" #Kidneycancer
#rcc
0
0
5
RT @DrChoueiri: IT IS THIS TIME OF THE YEAR AGAIN! TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024 1/ Enfortumab Vedotin (EV) + Pembroliz…
0
242
0
RT @APCCC_Lugano: AGREE II Quality Assessment of National and International Clinical Practice Guidelines on Prostate Cancer Management by t…
0
18
0
Uråldrat system som ska ersätta ett uråldrat inarbetat system. Då spelar snabb eller långsam utrullning ingen roll. #göromgörrätt
0
0
1
RT @magnusfovaeus: För två år sen blev det känt att Millennium orsakade minst fyra dödsfall och sex incidenter när systemet testades vid et…
0
17
0
RT @LoebStacy: New multi-dimensional questionnaire for sexual dysfunction after radical prostatectomy w 6 domains: erectile function, sexua…
0
6
0
RT @PGrivasMDPhD: So excited to see Dr. Suma Konety presenting on the rapidly developing field of cardio-oncology & implications on prostat…
0
7
0
RT @nataliagandur: 💫🌟 Next generation Imaging in the Metastatic Setting Presented by Karolien Goffin🌟💫 Moderator: @PGrivasMDPhD
#PROSCA24 @…
0
18
0
RT @nataliagandur: 💫🌟Update lecture: Cardiovascular complications related to hormonal therapy: identification, assessment, and management 🎓…
0
11
0
@nataliagandur @OncoAlert @mirrorsmed Thank you to to the organisers for an excellent #RENALC session of RENALC-BLADDR-PROSCA 2024 Hybrid Global Forum on GU Oncology. Excellent summary by @nataliagandur The #BLADDR session also very rewarding. Sad to miss out on #PROSCA coming up.
1
0
2
RT @PGrivasMDPhD: Fantastic talk by @DanieleRaggi83 on ADCs in advanced urothelial Ca #BLADDR24 @OncoAlert @mirrorsmed Huge progress, stil…
0
14
0
0
7
16
RT @tompowles1: The EMA has approved Enfortumab Vedotin and pembrolizumab for 1st line urothelial cancer. It supersedes 1st platinum based…
0
108
0
RT @LauraBukavinaMD: This just study shows that statistics are like a drunk with a lamppost: used more for support than illumination … sa…
0
2
0
RT @AndreaNecchi: 📬 Finally out in @TheLancetOncol the results from Cohort B of KN057 trial. Pembro in BCG-unresponsive papillary tumors w/…
0
25
0